Inventiva (IVA) Enterprise Value (2018 - 2025)
Inventiva's (IVA) quarterly Enterprise Value came in at -$268.8 million in Q4 2025, down 255.99% year-on-year from $172.3 million in Q4 2024, and up 99.81% quarter-over-quarter from -$138.2 billion in Q2 2025.
Inventiva (IVA) Enterprise Value (2018 - 2025) Analysis & Trends
Inventiva's Enterprise Value history runs 8 years deep, the most recent figure standing at -$268.8 million for Q4 2025.
- On a quarterly basis, Enterprise Value fell 255.99% year-over-year to -$268.8 million in Q4 2025; TTM through Dec 2025 was -$268.8 million, a 255.99% decrease from a year earlier, with the FY2025 full-year figure at -$268.8 million, down 255.99% from the prior year.
- Enterprise Value improved to -$268.8 million in Q4 2025 per IVA's latest filing, from -$138.2 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$4173.8 in Q3 2022 and bottomed at -$138.2 billion in Q2 2025.
- The 5-year median for Enterprise Value is -$85.1 million (2023), against an average of -$10.7 billion.
- Across the five-year window, Enterprise Value jumped 99.07% in 2022 and tumbled 458796.09% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$97.8 million in 2021, then grew by 9.53% to -$88.5 million in 2022, then surged by 88.99% to -$9.7 million in 2023, then tumbled by 674.96% to -$75.5 million in 2024, then plunged by 255.99% to -$268.8 million in 2025.
- Per Business Quant, the three latest IVA Enterprise Value figures stand at -$268.8 million (Q4 2025), -$138.2 billion (Q2 2025), and -$75.5 million (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | -268.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -268.78 Mn |
| Jun 30, 2025 | -138.20 Bn |
| Dec 31, 2024 | -75.50 Mn |
| Jun 30, 2024 | -30.12 Mn |
| Dec 31, 2023 | -9.74 Mn |
| Oct 11, 2023 | -12.54 Mn |
| Jun 30, 2023 | -85.08 Mn |
| Dec 31, 2022 | -88.50 Mn |
| Sep 22, 2022 | -4,173.76 |
| Jun 30, 2022 | -1.04 Mn |
| Dec 31, 2021 | -97.82 Mn |
| Jun 30, 2021 | -111.50 Mn |
| Mar 31, 2021 | -130.04 Mn |
| Dec 31, 2020 | -124.81 Mn |
| Jun 30, 2020 | -56.47 Mn |
| Dec 31, 2019 | -38.90 Mn |
| Dec 31, 2018 | -64.71 Mn |